Development of a Portable Ion Mobility Spectrometer For Efficient Diagnosis of Various Diseases
开发便携式离子淌度光谱仪以有效诊断各种疾病
基本信息
- 批准号:10708021
- 负责人:
- 金额:$ 37.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-22 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAntibiotic ResistanceBiological MarkersClinicalCommunitiesComplementComplexDetectionDevelopmentDevicesDiagnosisDiagnostic EquipmentDiagnostic testsDiseaseHospitalizationIonsIsomerismLeadMethodsMolecular StructureNursesPatient CarePersonsPlayPreparationRecoveryResearchResolutionResource-limited settingRoleSamplingStructureTechnologyTravelTubeValidationVariantadvanced analyticsbiomarker identificationclinical careconformerdiagnostic biomarkerfoodbornehigh throughput analysisinnovationinterestion mobilityionizationmobility aidnew technologynovel strategiespoint-of-care diagnosticsportabilityrapid diagnosisskillstargeted biomarkerusability
项目摘要
Development of a Portable Ion Mobility Spectrometer for Efficient Diagnosis of various diseases
This research will focus on the identification of the biomarkers associated with various diseases and the
development and validation of an innovative high-resolution ion mobility (IM) device. The proposed device is
based on a new variant of Structures for Lossless Ion Manipulations (SLIM) and will couple high-resolution ion
mobility separations achieved by traveling wave (TW)-SLIM with drift tube (DT)-SLIM which is a novel approach
that can provide collision cross section (CCS) values of the separated isomers/conformers that are unique to the
target biomarkers of interest. We expect this capability to increase biomarkers’ identification accuracy. In
addition, by combining the attributes of the high-resolution ion mobility and ambient ionization, sensitive
detection, and superior separation power will be achieved in the analysis of complex clinical samples without
any prior sample preparation.
The current diagnosis methods are often slow, expensive, or laborious which limits their use in resource-limited
regions. Therefore, there is a strong unmet need for new technologies that can rapidly diagnose various diseases
to complement the existing commercially available technologies. Rapid identification of diagnostic biomarkers in
clinical samples will not only lead to an increase in recovery rates but also will lead to shorter hospitalization
stays and reduced antibiotic resistance. We aim to develop a portable IM diagnostic device that can be used for
the identification of the biomarkers associated with foodborne and Alzheimer’s diseases which significantly
impact the lives of millions of people. The significance of these diseases causes diagnostic tests to play a major
role in the clinical care of patients suffering from these diseases Our studies will enable high throughput analyses
that are affordable and so easy-to-operate that can be performed by less-skilled users, such as nurses and their
assistants. Over the long term, these studies will be extended to multiple applications that span from the
fundamental studies of molecular structure elucidation to advanced analytical applications such as a widely
usable point-of-care diagnostic device that can serve the community, especially resource-limited regions.
1
便携式离子迁移谱仪的研制
本研究将集中于鉴定与各种疾病相关的生物标志物,
创新的高分辨率离子迁移率(IM)设备的开发和验证。申报器械
基于无损离子操纵结构(SLIM)的新变体,
采用行波SLIM和漂移管SLIM实现了迁移率分离
其可以提供对所述异构体/构象异构体唯一的分离的异构体/构象异构体的碰撞截面(CCS)值。
目标生物标志物。我们希望这种能力能够提高生物标志物识别的准确性。在
此外,通过结合高分辨率离子迁移率和环境电离的属性,
检测,并且在分析复杂的临床样品时将实现上级分离能力,
任何先前的样品制备。
目前的诊断方法往往是缓慢的,昂贵的,或费力的,这限制了它们在资源有限的情况下的使用。
地区因此,对能够快速诊断各种疾病的新技术存在强烈的未满足需求
以补充现有的商用技术。快速鉴定诊断性生物标志物
临床样本不仅可以提高治愈率,还可以缩短住院时间
减少抗生素耐药性。我们的目标是开发一种便携式IM诊断设备,可用于
确定与食源性疾病和阿尔茨海默病相关的生物标志物,
影响着数百万人的生活。这些疾病的重要性导致诊断测试发挥主要作用
我们的研究将使高通量分析成为可能
其是负担得起的并且易于操作的,其可以由不太熟练的用户(诸如护士及其护理人员)来执行。
助手从长远来看,这些研究将扩展到从
分子结构解析的基础研究,以先进的分析应用,如广泛的
可用的床旁诊断设备,可以服务于社区,特别是资源有限的地区。
1
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ahmed Mohamed Hamid其他文献
Ahmed Mohamed Hamid的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 37.41万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 37.41万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 37.41万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 37.41万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 37.41万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 37.41万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 37.41万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 37.41万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 37.41万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 37.41万 - 项目类别: